The Ultimate Validation of a Successful Randomized Clinical Trial
27 Tru-Ds Purchased to Date Among the BETR-D Hospitals
“I think it’s an important tool to have to prevent these infections from happening. All nine hospitals in the study, including our own here at Duke, have purchased these types of machines to continue to use even though the study has completed.”
Deverick Anderson, MD
BETR-D Study Participant Hospital
While the facility already had one Tru-D robot, it invested in two additional units following the completion of the BETR-D Study. Overall, infections by superbugs have decreased by +12% at ARMC, and the goal is to reach zero infections through the use of Tru-D and other protective measures.
Chesapeake Regional Healthcare:
BETR-D Study Participant Hospital
Chesapeake Regional purchased four Tru-Ds after the BETR-D Study was complete. It experienced a significant decrease in both infection and colonization rates with all multidrug-resistant organisms (MDROs) and about a 12% decrease in C. diff infections during the arms of the study that included Tru-D units and bleach.
- 1 Tru-d designated for OR
- 3 Tru-Ds focused on C. diff
- CRH longer monitors cleaning with pH pens
- Focus on utilization resulted in infection reduction
There’s Clean and then There’s St. Jude Clean: St. Jude Children’s Research Hospital
Nearly every child at St. Jude has a fragile immune system and a high risk of acquiring infections. “That’s why it’s critical not just to follow minimal requirements, but to take steps above and beyond to provide another layer of protection around our patients.”
Hana Hakim, MD
Medical Director of St. Jude Infection Prevention and Control
University of Wisconsin Health: SHEA 2017
UW is serious about providing the safest environment for patient care including broad utilization of a sporicidal disinfectant, an established antibiotic stewardship program and a quality assurance program for monitoring cleaning of high touch surfaces. In 2016, a number of interventions were implemented anew or intensified if already in use to further lower hospital onset C. diff infection rates. Among the interventions was the deployment of fourteen Tru-D SmartUVC UV disinfection robots which were implemented for all C. diff discharges. By the end of 2016, hospital onset C. diff dropped significantly.
- 14 Tru-Ds purchased
- Mandatory UV disinfection of all C. diff discharges
- Multiple IP modalities previously implemented
- Tru-D implementation had significant impact – 39% C. diff reduction
Lehigh Valley Health Network
An early adopter of Tru-D, Lehigh Valley has nine units among its campuses which has more than 1,000 beds. Deployed after every C. diff, norovirus and CRE discharge case, Lehigh Valley also utilizes the robots in its cardiac cath lab, burn units, labor and delivery rooms and radiology areas. Chosen for its Sensor360 technology, Lehigh Valley found that among competitors, Tru-D offered the greatest element of safety for its patients and staff, assuring every room is truly clean. Today, Tru-D continues to be an integral part of the Lehigh Valley environmental services team and a standard of care for every patient who walks in the door.
Sarasota Memorial Hospital
In the summer of 2014, Sarasota Memorial Hospital began to look at various enhanced cleaning technologies to add to its arsenal of cleaning strategies. With the onslaught of the Ebola breakout, the hospital ramped up its efforts to find a proactive solution to such infectious diseases and tested several UV disinfection robots. Due to its patented Sensor360 technology that analyzes a space and administers the proper, lethal dosage of UV light, Tru-D was selected as the device of choice. After implementing one Tru-D in its operating room, the hospital’s foundation purchased two additional units that are rotated throughout the hospital with a goal of disinfecting 100% of C. diff patients’ rooms.